Stock Update (NYSE:PFE): U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

[Reuters] – A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for . . . → Read More: Stock Update (NYSE:PFE): U.S. jury clears Pfizer in second trial alleging Zoloft birth defects Similar Articles: Stock Update: Lorillard Inc (NYSE:LO) – Reynolds-Lorillard merger clears final hurdle, judge okays brand transfer Company Update: Hewlett-Packard Company (NYSE:HPQ) – Columbus company’s jury verdict against HP upheld, raised to $8M Company Update (NYSE:PFE): Pfizer, Lilly to resume late-stage study testing pain drug